Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.
Diabetes Obes Metab
; 16(2): 159-69, 2014 Feb.
Article
in En
| MEDLINE
| ID: mdl-23906445
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzhydryl Compounds
/
Blood Glucose
/
Glycated Hemoglobin
/
Weight Loss
/
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
/
Glucosides
/
Metformin
Type of study:
Clinical_trials
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Diabetes Obes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2014
Type:
Article
Affiliation country:
Sweden